Information Library
Results for: Cardiovascular - Clinical Monitoring
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Constant Vigilance
Case Study — March 16, 2011
Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met. -
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
A Lock on Consistency
Case Study — February 1, 2011
A double-blind, randomized, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction. -
Acute Coronary Syndrome - Tailored Solutions
Case Study — February 1, 2011
Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO. -
Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India
Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.
-
Flexible Capacity
Case Study — November 24, 2010
Working with an ally who could deliver process efficiencies and cost-savings on a global scale, this company was able to expand its global portfolio. -
On-Time Results
Case Study — September 14, 2010
The commitment of the Quintiles team to the delivery of the study on time despite significant problems outside our control proved decisive in this global trial. -
Unrivalled Global Reach
Case Study — February 22, 2010
Failure was never an option with Quintiles’ guiding this complex global chronic heart failure study. -
Sub-Saharan Africa Phase II/III Fact Sheet
Brochure — July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
Page 1 of 1 (9 results)